smart phone enabled nCiD Demo

smart phone enabled nCiD Demo from Bilcareltd

To learn more about this presentation/ meet ‘Team Bilcare’ for NEW cloud based smart phone enabled nCiD Demo mention YES in Comment Section or LIKE this post.  

Security Solutions for Pharma Packaging

Counterfeit plaguing pharmaceutical profit, image and patient health

The World Health Organization (WHO) estimates that up to 1 per cent of medicines available in the developed world are likely to be counterfeit. This figure rises to 10 per cent globally, but in some areas of Asia, Africa and Latin America counterfeit goods can form up to 30 per cent of the market. The WHO estimates that 50 per cent of medicines available from unsolicited online websites are counterfeit, in some areas of Asia, Africa and Latin America counterfeit medical goods can form up to 30% of the market. INTERPOL Storm meeting looks to enhance investigative expertise in pharmaceutical crime. According to Outsourcing Pharma citing the European Commission, 75% of counterfeit drugs supplied world over have some origins in India, followed by 7% from Egypt and 6% from China. Brand Protection is central to any brand and organizational value, while beholding its image and avoiding revenue and reputation loss. Counterfeit is a growing problem that affects almost all sectors, including pharmaceuticals; further, organization need to develop strategies to face these external threats and this where- Bilcare’s cloud based authentication /anti-counterfeit technology (ACF Technology), which would be savoir to both pharma brand owners and patients

Bilcare Academy Event to Kick Off

“Bilcare Academy” Event to Kick Off Contract Pharma’s 15th Annual Contracting and Outsourcing Conference in September

Bilcare Research experts to deliver featured presentation: “The Role of Packaging Materials in Pharmaceutical Product Stability”

Bilcare Research Inc., one of the world’s largest manufacturers of blister packaging solutions, will host an educational event, dubbed Bilcare Academy, covering a range of topics dealing with the crucial role that packaging plays in the pharmaceutical life cycle. The event will take place at the Hyatt Regency in New Brunswick, NJ on September 21 – a day before the 15th Annual Contract Pharma Contracting and Outsourcing Conference & Tabletop Exhibition.

Bilcare Academy will entail in-depth discussions concerning the use of scientific models in packaging design to expedite the development process and overcome existing resource challenges, as well as a special 11:00am luncheon presentation, titled “The Role of Packaging Materials in Pharmaceutical Product Stability.”
To register for Bilcare Academy, contact Bilcare Research by emailing Chuck.Newswanger@bilcare.com, or calling (302) 256-7089.


Among other topics, industry packaging experts will discuss trends in high-barrier blister materials, consideration of sustainability in pharmaceutical packaging, and the company’s groundbreaking methods for streamlining paths to optimum product packaging.

Meet the Bilcare Research Global Pharma Team at Pharmapack Europe Booth 841| Porte de Versailles | Paris | France

The Global Pharma Team will be exhibiting for the 4th year in a row at the Pharmapack in Paris. Bilcare will share the latest developments in its offer to the pharmaceutical packaging market. Besides packaging materials itself, Bilcare  offers its expertise in packaging design and drug delivery systems fitting to patients’ needs

http://www.bilcaresolutions.com/upload/media/media/1/Bilcare_Reasearch_at_Pharmapack_Europe_PR_EN_020316%5B571%5D.pdf

Bilcare Research Segregates Pharma-Related Production Operations

Bilcare Research Inc., a division of one of the world’s largest manufacturers of blister packaging solutions, has begun segregating pharma-related production operations from those servicing other industries at its Wilmington, DE facility. The decision showcases Bilcare‘s commitment to the pharmaceutical sector amid growing customer demand and heightened quality control expectations.
Part of the global Pharmaceutical Packaging Innovation (PPI) Business Unit of Bilcare Research AG,   Bilcare Research offers a variety of mono and barrier blister films to the pharmaceutical packaging industry.  In addition to manufacturing pharmaceutical blister films, the company also produces products for other business units of the company.

With growing customer demand and a steadily increasing market share in the pharmaceutical films sector, Bilcare’s effort to separate its PPI production and storage area from areas servicing other businesses has the purpose of clearly differentiating its production process along industry-specific lines.  The result is the ability to service all sectors more efficiently.

Distributional

“We are dedicated to our pharmaceutical customers and this is just one more example of how,” said Kevin Stevens, President and Managing Director of Bilcare Research Inc. “Our strategy is to exceed our customers’ expectations in the quality of Bilcare’s products; the new plant layout shows our commitment and investment to that end. Packaging pharmaceutical products in an ideal fashion calls for a dedicated, siloed production environment throughout the supply chain, and we aim to set the bar high toward that goal.”

Bilcare Pharma Packaging Strategy

Packaging is defined as the collection of different components which surround the pharmaceutical product from the time of production until its use. Pharma packaging products is a broad, encompassing, and multi-faceted task. At Bilcare Packaging is responsible for providing life-saving drugs, medical devices, medical treatments, and new products like medical nutritionals in every imaginable dosage form to deliver every type of supplement, poultice, liquid, solid, powder, suspension, or drop to people the world over. It is transparent to the end user when done well and is open to criticism from all quarters when done poorly.

Distribution of products is now more global than ever. Mass customization of packaging to permit its use in multiple markets is a topic that needs exposition and discussion. Environmental issues, including sustainability, will always be a subjective dimension to any packaging design. Pharma Packaging is an emerging science, an emerging engineering discipline, and a success contributor to pharmaceutical industries.

Packaging can reside, or report through research and development (R and D), engineering, operations, purchasing, marketing, or the general administrative department of a company. For the majority of products produced in Bilcare it is probably the single largest aggregate purchase made by a company of materials critical to the protection, distribution, and sale of the product.

Dr. A P J Abdul Kalam at the 43rd Annual General Meeting of OPPI.

Highlights of Dr. A P J Abdul Kalam comments on Innovative Packaging at the 43rd Annual General Meeting of OPPI.

Visit : http://www.bilcare.com/insight/dimensions_of_healthcare.htm